Facility

Novo Nordisk today announced plans to invest $4.1 billion to build a new manufacturing facility in North Carolina. The Denmark-based company will build a second fill and finishing manufacturing facility in Clayton, North Carolina, to grow its ability to produce current and future injectable treatments for people with obesity and other serious chronic diseases. Novo…

Vetter recently announced it is expanding its development services sites in the U.S. and is planning for major investments in Germany. The company announced plans to move and expand its Development Services site from Skokie, Illinois, to Des Plaines, Illinois. It plans to invest majorly in its commercial business in Saarland, Germany, to complement its…

French pharma giant Sanofi recently opened a pediatric and adult vaccine manufacturing facility on its Toronto campus. The facility officially opened on May 30. According to Sanofi, the new plant significantly increases its capacity to meet growing demand in Canada and around the world for pediatric and adult vaccines for pertussis (whooping cough), diphtheria and…

Integrated DNA Technologies (IDT) recently announced the opening of a new 25,000 ft2 plant for synthetic biology products. Proximate to IDT’s flagship U.S. headquarters in Coralville, Iowa, the facility doubles IDT’s synthetic biology footprint, according to a May 28 news release. IDT officials see it furthering the company’s gene synthesis portfolio with differentiated offerings of…

Thermo Fisher Scientific announced that it opened a new clinical and commercial ultra-cold facility in the Netherlands. The company aims to expand its clinical trial network in Europe and accelerate the development of advanced therapies. Its new current good manufacturing practice (cGMP) facility in Bleiswijk offers pharmaceutical and biopharma customers tailored, end-to-end support throughout the…

Sen-Jam Pharmaceutical this week announced it is partnering with specialty pharmaceutical manufacturer KVK-Tech for formulation and chemistry, manufacturing and controls for anti-inflammatory injectables. The partnership is the third development, manufacturing, distribution and license agreement the pair have signed. The new partnership will further advance Sen-Jam’s first injectable anti-inflammatory therapeutic, SJP-100. Sen-Jam is developing an immunomodulator…

Fujifilm Diosynth Biotechnologies is investing $1.2 billion to expand its biopharmaceutical manufacturing facility in Holly Springs, N.C. Fujifilm initially invested $2 billion in the Holly Springs operation in 2021. The company said the investment made it one of North America’s largest end-to-end biopharmaceutical manufacturing facilities. The new expansion will create 680 new jobs in the…

Kintara Therapeutics and TuHURA recently announced they entered into a definitive merger agreement. The agreement is an all-stock transaction that will form a company with the expertise and resources needed to advance a risk-diversified late-stage oncology pipeline. The transaction is expected to close in Q3 2024. Kintara Therapeutics is a biopharmaceutical company investigating REM-001 in…

Pharma packaging company Schott Pharma has unveiled plans to establish a new manufacturing facility in Wilson, North Carolina. Schott Pharma says the $371 million investment in the U.S. facility will create more than 400 jobs in the region and significantly expand the company’s presence in the U.S., an increasingly important strategic market for the German…

Pfizer recently announced that it will wind down the construction of an Everett, Washington cancer therapies manufacturing plant that it inherited through its $43 billion acquisition of Seagen last year. Over the summer before the acquisition closure in December 2023, Seagen had inked a $215 million deal with contractor Skanksa  to build the 270,000-square-foot facility,…